Trump Says Becton Dickinson to Invest $3 Billion to Expand US Medical Product Manufacturing
The deal includes tariff relief tied to milestones and aims to lift domestic output by about 5 billion medical consumables a year, the company said.
- On Tuesday, Becton Dickinson announced a $3 billion partnership with the U.S. government to expand domestic manufacturing of essential medical consumables used in approximately 90% of U.S. hospital visits.
- The Trump administration's September 2025 Section 232 investigation into imported medical devices preceded this deal; the agreement provides relief from potential future tariffs, contingent on BD achieving undisclosed milestones.
- In Nebraska, BD will invest more than $1 billion to expand production, including needles made with American steel; the company committed to manufacturing 100% of its needles used in America domestically.
- The investment will expand end-to-end U.S. production by approximately 5 billion essential medical consumables annually, raising BD's domestic market share to roughly 80%.
- CEO Tom Polen stated the move aligns with BD's strategy as a focused pure-play MedTech company; the company is not currently quantifying the agreement's financial impact until Section 232 tariffs are finalized.
12 Articles
12 Articles
Trump says Becton Dickinson to invest $3 billion to expand US medical product manufacturing
American medical technology company Becton Dickinson has agreed to invest $3 billion to bring manufacturing of essential medical products to the United States, President Donald Trump said on Monday in a post on the Truth Social website.
BD and U.S. Government Launch Landmark Partnership to Expand U.S. Manufacturing and Strengthen America's Healthcare Resilience
/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), one of the world's leading medical technology companies and the nation's largest manufacturer...
Trump: BD to invest $3B in U.S. medical equipment manufacturing, including $1B in Nebraska
President Donald Trump has announced a major partnership with a leading medical technology company to gain a $3 billion investment in American hospital equipment manufacturing.
US President Donald Trump stated that Becton Dickenson, one of the world's largest medical supply companies, has agreed to invest in local manufacturing of essential medical products (such as syringes, needles, laboratory supplies, and others) relied upon by patients and hospitals in America. This coincided with Becton's announcement of a strategic partnership with the US government to invest $19 billion over several years. [The article "Trump A…
Coverage Details
Bias Distribution
- 71% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
